From the annual meeting of the American Society of Hematology (ASH) in San Francisco.
The very international gathering at the ASH meeting in San Francisco included some attendees who seemed delighted to be in the United States for their first time since the U.S. presidential election, and almost giddy over our choice for president.
One physician from Hong Kong ended his presentation at a press conference by asking, Can we bring change to the treatment of idiopathic thrombocytopenic purpura (ITP) and give patients with refractory disease new hope by offering the experimental drug eltrombopag? And answering his own question with, “Yes, we can!”
Another physician from Germany ended his part of the press conference by saying — Can we change our platelet transfusion strategy to hold off on transfusions until there is clinically significant bleeding. “I will say with your president-elect, we can!”
Those were cute. But two days later after an Italian physician presented his study at a plenary session, a British colleague stepped to the microphone during Q&A and asked, apropos of nothing, “Are you happy about the new president?” Seeing the look of bewilderment on the presenter’s face, the Brit added, “I mean the United States president.” Just in case people thought he was talking about the new ASH president.
I like Obama as much as the next person, but can we move on from campaign sloganeering now? Yes, we can.
— Sherry Boschert